vs
Alignment Healthcare, Inc.（ALHC）与科睿唯安（CLVT）财务数据对比。点击上方公司名可切换其他公司
Alignment Healthcare, Inc.的季度营收约是科睿唯安的2.1倍（$1.2B vs $585.5M），Alignment Healthcare, Inc.净利率更高（0.9% vs -6.9%，领先7.8%），科睿唯安同比增速更快（-1.4% vs -74.7%），过去两年Alignment Healthcare, Inc.的营收复合增速更高（34.6% vs -5.1%）
Alignment Healthcare是总部位于美国的医疗保健企业，主打联邦医疗保险优势计划，为老年群体提供协调医疗服务、处方药保障及补充福利，采用价值导向医疗模式，与本土医疗机构合作，业务覆盖美国多个州，致力提升患者健康水平。
科睿唯安是一家英美合资的上市分析服务企业，主要提供订阅制信息服务，覆盖文献计量、科学计量、商业与市场情报领域，同时为医药、生物科技行业提供专利、监管合规相关的竞争分析，也提供商标保护、域名与品牌保护服务，旗下Web of Science产品系列还负责计算学术期刊的影响因子。
ALHC vs CLVT — 直观对比
营收规模更大
ALHC
是对方的2.1倍
$585.5M
营收增速更快
CLVT
高出73.4%
-74.7%
净利率更高
ALHC
高出7.8%
-6.9%
两年增速更快
ALHC
近两年复合增速
-5.1%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $585.5M |
| 净利润 | $11.4M | $-40.2M |
| 毛利率 | — | 67.2% |
| 营业利润率 | — | 5.2% |
| 净利率 | 0.9% | -6.9% |
| 营收同比 | -74.7% | -1.4% |
| 净利润同比 | — | 61.3% |
| 每股收益（稀释后） | — | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALHCCLVT
| Q1 26 | $1.2B | $585.5M | ||
| Q4 25 | $1.0B | $617.0M | ||
| Q3 25 | $993.7M | $623.1M | ||
| Q2 25 | $1.0B | $621.4M | ||
| Q1 25 | $926.9M | $593.7M | ||
| Q4 24 | $701.2M | $663.0M | ||
| Q3 24 | $692.4M | $622.2M | ||
| Q2 24 | $681.3M | $650.3M |
净利润ALHCCLVT
| Q1 26 | $11.4M | $-40.2M | ||
| Q4 25 | $-11.0M | $3.1M | ||
| Q3 25 | $3.7M | $-28.3M | ||
| Q2 25 | $15.7M | $-72.0M | ||
| Q1 25 | $-9.1M | $-103.9M | ||
| Q4 24 | $-31.1M | $-191.8M | ||
| Q3 24 | $-26.4M | $-65.6M | ||
| Q2 24 | $-24.0M | $-304.3M |
毛利率ALHCCLVT
| Q1 26 | — | 67.2% | ||
| Q4 25 | — | 66.8% | ||
| Q3 25 | — | 65.0% | ||
| Q2 25 | — | 67.2% | ||
| Q1 25 | — | 65.1% | ||
| Q4 24 | — | 65.7% | ||
| Q3 24 | — | 66.2% | ||
| Q2 24 | — | 67.2% |
营业利润率ALHCCLVT
| Q1 26 | — | 5.2% | ||
| Q4 25 | -1.0% | 6.7% | ||
| Q3 25 | 0.8% | 7.1% | ||
| Q2 25 | 2.2% | 1.1% | ||
| Q1 25 | -0.6% | -3.5% | ||
| Q4 24 | -3.2% | -9.4% | ||
| Q3 24 | -2.8% | 3.5% | ||
| Q2 24 | -2.7% | -36.9% |
净利率ALHCCLVT
| Q1 26 | 0.9% | -6.9% | ||
| Q4 25 | -1.1% | 0.5% | ||
| Q3 25 | 0.4% | -4.5% | ||
| Q2 25 | 1.5% | -11.6% | ||
| Q1 25 | -1.0% | -17.5% | ||
| Q4 24 | -4.4% | -28.9% | ||
| Q3 24 | -3.8% | -10.5% | ||
| Q2 24 | -3.5% | -46.8% |
每股收益（稀释后）ALHCCLVT
| Q1 26 | — | $-0.06 | ||
| Q4 25 | $-0.04 | $0.00 | ||
| Q3 25 | $0.02 | $-0.04 | ||
| Q2 25 | $0.07 | $-0.11 | ||
| Q1 25 | $-0.05 | $-0.15 | ||
| Q4 24 | $-0.15 | $-0.27 | ||
| Q3 24 | $-0.14 | $-0.09 | ||
| Q2 24 | $-0.13 | $-0.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $705.6M | — |
| 总债务越低越好 | — | $4.3B |
| 股东权益账面价值 | $206.9M | $4.8B |
| 总资产 | $1.3B | $10.9B |
| 负债/权益比越低杠杆越低 | — | 0.89× |
8季度趋势，按日历期对齐
现金及短期投资ALHCCLVT
| Q1 26 | $705.6M | — | ||
| Q4 25 | $604.2M | $329.2M | ||
| Q3 25 | $644.1M | $318.7M | ||
| Q2 25 | $503.8M | $362.6M | ||
| Q1 25 | $479.5M | $354.0M | ||
| Q4 24 | $470.6M | $295.2M | ||
| Q3 24 | $381.0M | $388.5M | ||
| Q2 24 | $363.7M | $376.4M |
总债务ALHCCLVT
| Q1 26 | — | $4.3B | ||
| Q4 25 | $323.2M | $4.3B | ||
| Q3 25 | $322.7M | $4.4B | ||
| Q2 25 | $322.3M | $4.5B | ||
| Q1 25 | $321.9M | $4.5B | ||
| Q4 24 | $321.4M | $4.5B | ||
| Q3 24 | $212.0M | $4.6B | ||
| Q2 24 | $211.7M | $4.6B |
股东权益ALHCCLVT
| Q1 26 | $206.9M | $4.8B | ||
| Q4 25 | $179.3M | $4.8B | ||
| Q3 25 | $161.9M | $4.9B | ||
| Q2 25 | $141.0M | $5.0B | ||
| Q1 25 | $108.1M | $5.0B | ||
| Q4 24 | $99.9M | $5.1B | ||
| Q3 24 | $114.5M | $5.5B | ||
| Q2 24 | $123.7M | $5.6B |
总资产ALHCCLVT
| Q1 26 | $1.3B | $10.9B | ||
| Q4 25 | $1.1B | $11.1B | ||
| Q3 25 | $1.1B | $11.2B | ||
| Q2 25 | $1.0B | $11.4B | ||
| Q1 25 | $895.6M | $11.5B | ||
| Q4 24 | $782.1M | $11.5B | ||
| Q3 24 | $692.3M | $12.0B | ||
| Q2 24 | $716.3M | $12.1B |
负债/权益比ALHCCLVT
| Q1 26 | — | 0.89× | ||
| Q4 25 | 1.80× | 0.89× | ||
| Q3 25 | 1.99× | 0.90× | ||
| Q2 25 | 2.29× | 0.90× | ||
| Q1 25 | 2.98× | 0.90× | ||
| Q4 24 | 3.22× | 0.88× | ||
| Q3 24 | 1.85× | 0.84× | ||
| Q2 24 | 1.71× | 0.83× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $128.7M | $134.7M |
| 自由现金流经营现金流 - 资本支出 | — | $78.9M |
| 自由现金流率自由现金流/营收 | — | 13.5% |
| 资本支出强度资本支出/营收 | — | 9.5% |
| 现金转化率经营现金流/净利润 | 11.27× | — |
| 过去12个月自由现金流最近4个季度 | — | $333.9M |
8季度趋势，按日历期对齐
经营现金流ALHCCLVT
| Q1 26 | $128.7M | $134.7M | ||
| Q4 25 | $-50.4M | $159.9M | ||
| Q3 25 | $144.6M | $181.1M | ||
| Q2 25 | $29.1M | $116.3M | ||
| Q1 25 | $16.6M | $171.2M | ||
| Q4 24 | $-8.7M | $141.3M | ||
| Q3 24 | $26.2M | $202.9M | ||
| Q2 24 | $23.5M | $126.2M |
自由现金流ALHCCLVT
| Q1 26 | — | $78.9M | ||
| Q4 25 | $-55.4M | $89.2M | ||
| Q3 25 | $139.1M | $115.5M | ||
| Q2 25 | $21.1M | $50.3M | ||
| Q1 25 | $8.4M | $110.3M | ||
| Q4 24 | $-18.0M | $59.1M | ||
| Q3 24 | $16.9M | $126.3M | ||
| Q2 24 | $11.8M | $60.3M |
自由现金流率ALHCCLVT
| Q1 26 | — | 13.5% | ||
| Q4 25 | -5.5% | 14.5% | ||
| Q3 25 | 14.0% | 18.5% | ||
| Q2 25 | 2.1% | 8.1% | ||
| Q1 25 | 0.9% | 18.6% | ||
| Q4 24 | -2.6% | 8.9% | ||
| Q3 24 | 2.4% | 20.3% | ||
| Q2 24 | 1.7% | 9.3% |
资本支出强度ALHCCLVT
| Q1 26 | — | 9.5% | ||
| Q4 25 | 0.5% | 11.5% | ||
| Q3 25 | 0.6% | 10.5% | ||
| Q2 25 | 0.8% | 10.6% | ||
| Q1 25 | 0.9% | 10.3% | ||
| Q4 24 | 1.3% | 12.4% | ||
| Q3 24 | 1.3% | 12.3% | ||
| Q2 24 | 1.7% | 10.1% |
现金转化率ALHCCLVT
| Q1 26 | 11.27× | — | ||
| Q4 25 | — | 51.58× | ||
| Q3 25 | 38.77× | — | ||
| Q2 25 | 1.86× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALHC
暂无分部数据
CLVT
| Subscription | $397.5M | 68% |
| Re-occurring | $108.6M | 19% |
| Transactional | $79.4M | 14% |
